CytomX Therapeutics Eulerpool News

CytomX Therapeutics Eulerpool News

CytomX Therapeutics Notizie Azioni

CytomX Therapeutics è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie CytomX Therapeutics.

• 9 settembre ·

  Yahoo
  CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors
• 9 settembre ·

  GlobeNewswire
  CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY?, in a Phase 1 Study in Patients with Solid Tumors
• 4 settembre ·

  Yahoo
  CytomX Therapeutics to Present at Upcoming September Investor Conferences
• 10 agosto ·

  Yahoo
  CytomX Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
• 9 agosto ·

  SeekingAlpha
  CytomX Therapeutics, Inc. (CTMX) Q2 2024 Earnings Call Transcript
• 9 agosto ·

  TipRanks
  CytomX Therapeutics (CTMX) Gets a Buy from Wedbush
• 9 agosto ·

  Seeking Alpha
  CytomX Therapeutics files $250M mixed securities shelf
• 9 agosto ·

  TipRanks
  CytomX Therapeutics (CTMX) Receives a Buy from Barclays
• 8 agosto ·

  Yahoo
  CytomX Therapeutics: Q2 Earnings Snapshot
• 8 agosto ·

  Yahoo
  CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update